Next Article in Journal
Is It Easy to Synchronize Our Minds When We Are Forced to Cooperate?
Next Article in Special Issue
Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment
Previous Article in Journal
Association of Polygenic Liability for Alcohol Dependence and EEG Connectivity in Adolescence and Young Adulthood
Previous Article in Special Issue
Therapeutic Plasma Exchange in Multiple Sclerosis and Autoimmune Encephalitis: A Comparative Study of Indication, Efficacy, and Safety
Open AccessCase Report

Post-Craniopharyngioma and Cranial Nerve-VI Palsy Update on a MS Patient with Major Depression and Concurrent Neuroimmune Conditions

1
United States Department of Agriculture, Agricultural Research Service, USDA-ARS, New Orleans, Home 2261 Brighton Place, Harvey, LA 70058, USA
2
Department of Medicine, Fairfield Medical Center, 401 North Ewing, Lancaster, OH 43130, USA
3
Department of Neurobiology and Anatomy, Wake Forest School of Medicine, 1 Medical Center Boulevard, Winston-Salem, NC 27157, USA
4
Department of Neurology, Wake Forest School of Medicine, 1 Medical Center Boulevard, Winston-Salem, NC 27157, USA
5
Department of Neurobiology and Anatomy, The University of Mississippi Medical Center, Jackson, MS 39216, USA
6
Department of Radiology, Houston Methodist Hospital, 6565 Fannin Street, Houston, TX 77030, USA
7
Department of Ophthalmology, Ochsner Hospital, 1514 Jefferson Highway, New Orleans, 70121, USA
*
Author to whom correspondence should be addressed.
This author is retired.
Brain Sci. 2019, 9(10), 281; https://doi.org/10.3390/brainsci9100281
Received: 25 August 2019 / Revised: 6 October 2019 / Accepted: 11 October 2019 / Published: 17 October 2019
(This article belongs to the Special Issue Advances in Multiple Sclerosis Research)
We report the case of a male multiple sclerosis (MS) patient with type 2 diabetes (T2D), asthma, major depression (MD or major depressive disorder, MDD), and other chronic conditions, after his recent difficulties with craniopharyngioma and cranial nerve-VI (CN6) palsy. In addition, we show magnetic resonance image and spectroscopy (MRI, MRS), Humphrey’s Visual Field (HVF), and retinal nerve fiber layer thickness (RNFLT) findings to explain the changes in the patient’s health, and discuss the methods that helped/help him sustain productivity and euthymia despite long-standing problems and new CNS changes. View Full-Text
Keywords: major depression; multiple sclerosis; bupropion; S-adenosylmethionine; vitamin D3; yoga; craniopharyngioma; fractionated stereotactic radiation treatments; sphenoid sinusitis; cranial nerve-VI palsy major depression; multiple sclerosis; bupropion; S-adenosylmethionine; vitamin D3; yoga; craniopharyngioma; fractionated stereotactic radiation treatments; sphenoid sinusitis; cranial nerve-VI palsy
Show Figures

Figure 1

MDPI and ACS Style

Sachinvala, N.D.; Stergiou, A.; Haines, D.E.; Kocharian, A.; Lawton, A. Post-Craniopharyngioma and Cranial Nerve-VI Palsy Update on a MS Patient with Major Depression and Concurrent Neuroimmune Conditions. Brain Sci. 2019, 9, 281.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop